TCR2 THERAPEUTICS INC.
We are an innovative immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer
$14.00 - $16.00
February 14, 2019
Jefferies, Leerink Partners, BMO Capital Markets, Wedbush PacGrow, China Renaissance
To view the prospectus for TCR2 THERAPEUTICS INC. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277